Drug class in one race
SHP2 drugs for Non-Small Cell Lung Cancer
4 tracked SHP2 drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the SHP2 page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 31 Phase 1/22 Phase 1
Head-to-head evidence: BBP-398 vs GH21 · BBP-398 vs HBI-2376 · BBP-398 vs JAB-3312 · GH21 vs HBI-2376 · GH21 vs JAB-3312 · HBI-2376 vs JAB-3312